Adherence to Long-Acting Inhaled Therapies among Patients with Chronic Obstructive Pulmonary Disease (COPD)

By Cecere Laura M.   Slatore Christopher G.   Uman Jane E.   Evans Laura E.   Udris Edmunds M.   Bryson Chris L.   Au David H.  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 3, 2012-05 ,pp. : 251-258

Informa Healthcare

Access to resources Recommend Favorite

Asthma Mortality and Long-Acting Beta2-Agonists in Five Major European Countries, 1994-2004

By Chatenoud Liliane   Malvezzi Matteo   Pitrelli Andrea   La Vecchia Carlo   Bamfi Francesco  

Journal of Asthma, Vol. 46, Iss. 6, 2009-08 ,pp. : 546-551

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

By Beier Jutta  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 511-522

Informa Healthcare

Access to resources Recommend Favorite

Long-Acting Beta-Agonists and the Risk of Intensive Care Unit Admission in Children

By Jacobs Tammy S.   Jones Bobby L.   MacGinnitie Andrew J.  

Journal of Asthma, Vol. 49, Iss. 5, 2012-06 ,pp. : 450-455

Informa Healthcare

Access to resources Recommend Favorite

Single Dose of Tiotropium Improves the 6-Minute Walk Distance in Chronic Obstructive Pulmonary Disease

By Okudan Nilsel   Gök Mehmet   Gökbel Hakkı   Süerdem Mecit  

Lung, Vol. 184, Iss. 4, 2006-08 ,pp. : 201-204

Springer Publishing Company

Access to resources Recommend Favorite